Adrian M Di Bisceglie Selected Research

Adrian M Di Bisceglie Research Topics

Disease

55	Fibrosis (Cirrhosis) 06/2021 - 11/2002
45	Infections 01/2021 - 03/2002
39	Hepatitis C 01/2021 - 11/2002
35	Chronic Hepatitis C 01/2020 - 11/2002
27	Hepatocellular Carcinoma (Hepatoma) 11/2019 - 05/2002
23	Liver Diseases (Liver Disease) 06/2021 - 11/2002
10	Neoplasms (Cancer) 01/2021 - 05/2002
7	Chronic Hepatitis B 01/2021 - 12/2007
7	Liver Cirrhosis (Hepatic Cirrhosis) 09/2013 - 03/2005
6	Hepatitis B 11/2019 - 05/2009
5	End Stage Liver Disease 06/2021 - 07/2005
5	Virus Diseases (Viral Diseases) 02/2015 - 11/2004
4	Fatty Liver 01/2021 - 01/2003
3	Ascites 06/2021 - 11/2005
3	Inflammation (Inflammations) 06/2021 - 01/2003
3	Viremia 11/2019 - 10/2004
3	Body Weight (Weight, Body) 12/2010 - 10/2008
3	Varicose Veins (Varicose Vein) 06/2010 - 11/2005
3	Hemorrhage 01/2010 - 12/2003
3	Disease Progression 11/2009 - 10/2004
2	Hepatitis 01/2021 - 10/2004
2	Weight Loss (Weight Reduction) 01/2021 - 12/2010
2	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2003
2	Hyperlipidemias (Hyperlipidemia) 11/2020 - 11/2019
2	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2017
2	Reinfection 01/2016 - 04/2004
2	Anemia 06/2011 - 12/2003
2	Persistent Infection 05/2011 - 03/2003
2	Fever (Fevers) 05/2010 - 12/2003
2	Coinfection 01/2010 - 04/2005
2	Necrosis 12/2003 - 01/2003
2	Superinfection 07/2003 - 09/2002
1	Alcoholic Fatty Liver 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Thrombotic Stroke 11/2020
1	Hypercholesterolemia 11/2020
1	Myocardial Infarction 11/2020

Drug/Important Bio-Agent (IBA)

45	Antiviral Agents (Antivirals)IBA 01/2021 - 11/2002
32	Ribavirin (Virazole)FDA LinkGeneric 02/2016 - 11/2002
24	InterferonsIBA 02/2016 - 01/2004
11	Biomarkers (Surrogate Marker)IBA 06/2021 - 06/2009
10	Proteins (Proteins, Gene)FDA Link 06/2021 - 06/2009
9	RNA (Ribonucleic Acid)IBA 12/2016 - 04/2004
8	peginterferon alfa-2a (Pegasys)FDA Link 06/2011 - 04/2004
6	Hepatitis B e AntigensIBA 01/2021 - 12/2007
6	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 08/2011
6	Alanine Transaminase (SGPT)IBA 01/2021 - 03/2009
6	BilirubinIBA 01/2021 - 11/2005
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2009
6	Complement System Proteins (Complement)IBA 01/2016 - 03/2002
5	AlbuminsIBA 01/2020 - 01/2010
5	SofosbuvirIBA 12/2016 - 04/2014
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2013 - 09/2005
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2004
4	telaprevirIBA 07/2014 - 04/2010
4	Interferon-alpha (Interferon Alfa)IBA 06/2009 - 01/2004
3	MicroRNAs (MicroRNA)IBA 10/2017 - 09/2013
3	ledipasvirIBA 12/2016 - 04/2014
3	Glycoproteins (Glycoprotein)IBA 07/2013 - 03/2002
3	Messenger RNA (mRNA)IBA 07/2013 - 05/2011
3	Kininogens (Kininogen)IBA 01/2013 - 06/2009
3	Neutralizing AntibodiesIBA 04/2006 - 03/2002
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2021 - 11/2005
2	BerberineIBA 01/2021 - 11/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2010
2	EnzymesIBA 01/2021 - 01/2003
2	sofosbuvir drug combination ledipasvirIBA 12/2016 - 05/2014
2	Rituximab (Mabthera)FDA Link 02/2015 - 05/2010
2	AntibodiesIBA 01/2013 - 03/2002
2	Polysaccharides (Glycans)IBA 06/2011 - 08/2010
2	Transaminases (Aminotransferases)IBA 05/2010 - 04/2006
2	Lamivudine (Epivir)FDA Link 01/2010 - 12/2007
2	IronIBA 06/2007 - 11/2006
1	Lipopolysaccharide ReceptorsIBA 06/2021
1	Immunoglobulins (Immunoglobulin)IBA 06/2021
1	Fatty Acid-Binding ProteinsIBA 06/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2021
1	Lactulose (Duphalac)FDA LinkGeneric 06/2021
1	lipopolysaccharide-binding proteinIBA 06/2021
1	clonidine-displacing substance (ClDS)IBA 01/2021
1	SaltsIBA 01/2021
1	LDL CholesterolIBA 11/2020
1	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 11/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2020
1	Oxidoreductases (Dehydrogenase)IBA 11/2020
1	Ezetimibe (Zetia)FDA Link 11/2020
1	CholesterolIBA 11/2020
1	Immune Checkpoint InhibitorsIBA 11/2020

Therapy/Procedure

54	Therapeutics 01/2021 - 11/2002
16	Liver Transplantation 01/2021 - 05/2002
4	Aftercare (After-Treatment) 06/2021 - 11/2004
4	Retreatment 04/2014 - 11/2006
4	Transplantation 10/2011 - 04/2004
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2019 - 10/2011
2	Duration of Therapy 02/2016 - 12/2010
2	Drug Therapy (Chemotherapy) 02/2015 - 05/2010
2	Transjugular Intrahepatic Portasystemic Shunt 06/2005 - 12/2003
2	Stents 06/2005 - 12/2003
1	Glycemic Control 01/2021